Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.1% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 79,944 shares of the company’s stock after buying an additional 4,569 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Option Care Health were worth $2,597,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of OPCH. Norges Bank purchased a new position in Option Care Health during the fourth quarter worth $51,009,000. BlackRock Inc. boosted its stake in Option Care Health by 8.5% during the first quarter. BlackRock Inc. now owns 21,444,169 shares of the company’s stock worth $681,281,000 after buying an additional 1,671,783 shares during the period. Point72 Asset Management L.P. boosted its stake in Option Care Health by 262.7% during the fourth quarter. Point72 Asset Management L.P. now owns 1,686,143 shares of the company’s stock worth $50,736,000 after buying an additional 1,221,200 shares during the period. Duquesne Family Office LLC boosted its stake in Option Care Health by 389.0% during the fourth quarter. Duquesne Family Office LLC now owns 1,526,120 shares of the company’s stock worth $45,921,000 after buying an additional 1,214,020 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Option Care Health by 8.1% during the third quarter. Vanguard Group Inc. now owns 15,269,619 shares of the company’s stock worth $480,534,000 after buying an additional 1,147,767 shares during the period. 94.75% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Up 1.3 %

NASDAQ:OPCH opened at $29.69 on Tuesday. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The company has a market cap of $5.26 billion, a price-to-earnings ratio of 21.06, a price-to-earnings-growth ratio of 1.01 and a beta of 1.20. The stock has a fifty day simple moving average of $31.28 and a 200-day simple moving average of $31.55. The company has a current ratio of 1.79, a quick ratio of 1.39 and a debt-to-equity ratio of 0.73.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, October 25th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02. The firm had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.09 billion. Option Care Health had a return on equity of 18.22% and a net margin of 6.12%. Analysts anticipate that Option Care Health, Inc. will post 1.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on OPCH shares. Barrington Research decreased their target price on Option Care Health from $41.00 to $35.00 and set an “outperform” rating for the company in a research report on Thursday, October 26th. JPMorgan Chase & Co. decreased their target price on Option Care Health from $46.00 to $44.00 and set an “overweight” rating for the company in a research report on Wednesday, October 18th.

Insider Activity at Option Care Health

In other news, Director Elizabeth D. Bierbower acquired 3,000 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was purchased at an average cost of $26.37 per share, for a total transaction of $79,110.00. Following the completion of the acquisition, the director now directly owns 13,515 shares of the company’s stock, valued at approximately $356,390.55. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.38% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.